Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Ovarian Neoplasms and VEGFA[original query] |
---|
Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trial. The pharmacogenomics journal 2015 Jul . He Y J, Winham S J, Hoskins J M, Glass S, Paul J, Brown R, Motsinger-Reif A, McLeod H |
Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial. JAMA oncology 2017 12 4 (2): 196-202. Richardson Debra L, Sill Michael W, Coleman Robert L, Sood Anil K, Pearl Michael L, Kehoe Siobhan M, Carney Michael E, Hanjani Parviz, Van Le Linda, Zhou Xun C, Alvarez Secord Angeles, Gray Heidi J, Landrum Lisa M, Lankes Heather A, Hu Wei, Aghajanian Car |
[The vascular endothelial growth factor in patients with advanced ovarian cancer on the background of chemotherapy according to the AP scheme.]. Klinicheskaia laboratornaia diagnostika 2019 2 63 (9): 543-548. Abakumova T V, Gening S O, Dolgova D R, Gening T P, Antoneeva I I, Poludnyakova L V, Kuznetsova T I, Dergunova Yu A, Panchenko E |
c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial. BMC medicine 2022 Feb 20 (1): 59. Morgan Robert D, Ferreras Cristina, Peset Isabel, Avizienyte Egle, Renehan Andrew G, Edmondson Richard J, Murphy Alexander D, Nicum Shibani, Van Brussel Thomas, Clamp Andrew R, Lambrechts Diether, Zhou Cong, Jayson Gordon |
- Page last reviewed:Feb 1, 2024
- Content source: